Back

Verigicuat: standard therapy for HFrEF?

9 May 2026 (08:45 - 09:00)
Organised by: Logo
Congress Presentation Part of: Controversies in contemporary drug therapy for heart failure Cardiovascular Pharmacotherapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

3 More presentations in this session

Presentation thumbnail
Digitoxin and digoxin: standard therapy for HFrEF?
Professor U. Bavendiek (Hannover, DE)
Slides Video
Presentation thumbnail
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?
Doctor A. Ruwald (Copenhagen, DK)
Slides Video
Presentation thumbnail
Controversies in contemporary drug therapy for heart failure - discussion
Video

Access the full session

Session thumbnail
Controversies in contemporary drug therapy for heart failure
Video

The Event

Event poster

Heart Failure 2026

9 May 2026 08:45 CET
You may be interested in
thumbnail
Congress Presentation
Vericiguat
20 May 2025
thumbnail
Congress Presentation
Effect of Vericiguat on Mortality in Ambulatory Patients with Heart Failure and Reduced Ejection Fraction: VICTOR Trial Prespecified Analysis
1 September 2025
thumbnail
Congress Presentation
What is coming now?
31 August 2025
thumbnail
Congress Presentation
Closing remarks.
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources